ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

31,723Medicare Part D Prescriptions Filled, Including Refills

Rank: 54 out of 3647

$2.62M Total Retail Price of All Prescriptions

Rank: 22 out of 3647

623 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
96% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 623 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

2% of this provider’s 623 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 29,107 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

42% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
POTASSIUM CHLORIDE 1,003 932 1 24
OMEPRAZOLE 928 831 2 3
SIMVASTATIN 879 821 3 1
NEXIUM 682 626 4 44
IBUPROFEN 670 580 5 55
LEVOTHYROXINE SODIUM 613 573 6 5
TRICOR 585 490 10 7 144
SINGULAIR 579 496 8 90
GABAPENTIN 575 541 9 17
FUROSEMIDE 545 484 10 8
ATENOLOL 534 498 11 10
LIDODERM 531 460 12 108
CLOPIDOGREL 515 482 13 26
DONEPEZIL HCL 479 461 14 30
ADVAIR DISKUS 468 422 15 52
GLYBURIDE-METFORMIN HCL 450 423 R 16 94
LISINOPRIL 441 403 17 4
PLAVIX 437 405 18 39
DIOVAN 426 405 19 40
FLUTICASONE PROPIONATE 396 351 20 32
SYMBICORT 390 358 21 153
DIOVAN HCT 345 309 22 80
RANITIDINE HCL 323 289 23 29
NAMENDA 317 295 24 49
PENTOXIFYLLINE 311 284 25 180
CELEBREX 287 241 26 111
METOPROLOL TARTRATE 283 272 27 7
DIGOXIN 278 276 28 51
PREDNISONE 266 249 29 43
METFORMIN HCL 261 261 30 6
SPIRIVA 246 219 31 93
TRAMADOL HCL 239 216 32 22
BENICAR 238 229 33 114
MONTELUKAST SODIUM 238 214 33 160
AMLODIPINE BESYLATE 234 218 35 2
TAMSULOSIN HCL 227 212 36 28
CRESTOR 220 179 37 19
MUPIROCIN 220 202 37 137
KLOR-CON 10 214 207 39 106
CLOTRIMAZOLE-BETAMETHASONE 213 178 40 84
COMBIVENT 212 168 41 170
VOLTAREN 211 200 42 102
CIPROFLOXACIN HCL 210 196 43 53
MECLIZINE HCL 209 192 44 85
CILOSTAZOL 199 199 45 168
HYDROCHLOROTHIAZIDE 196 175 46 9
THEOPHYLLINE ANHYDROUS 189 189 47 333
ALENDRONATE SODIUM 187 187 48 23
AZITHROMYCIN 187 176 48 34
CITALOPRAM HBR 186 183 50 25
ESCITALOPRAM OXALATE 184 180 51 65
BENICAR HCT 174 157 52 165
PROAIR HFA 173 160 53 62
DICLOFENAC SODIUM 171 164 54 86
MELOXICAM 164 145 55 33
AVODART 164 149 55 173
ENALAPRIL MALEATE 163 163 57 35
METOPROLOL SUCCINATE 162 150 58 18
EXFORGE HCT 161 142 59 342
LACTULOSE 153 126 60 128
ATORVASTATIN CALCIUM 153 134 60 13
MEGESTROL ACETATE 151 149 R 62 138
ZOLPIDEM TARTRATE 147 142 63 14
CYCLOBENZAPRINE HCL 141 120 R 64 98
LOVAZA 140 117 65 117
FAMOTIDINE 139 131 66 61
CLONIDINE HCL 138 136 67 46
SERTRALINE HCL 135 135 68 27
ALBUTEROL SULFATE 134 117 69 157
NAPROXEN 133 131 70 70
DEXILANT 124 106 71 207
SURE COMFORT 122 116 72 161
PEN NEEDLE 122 122 72 166
CYMBALTA 119 108 74 79
NOVOLIN 70-30 118 118 75 130
AMMONIUM LACTATE 118 111 75 141
AMLODIPINE BESYLATE-BENAZEPRIL 117 100 77 74
KETOCONAZOLE 114 102 78 132
PRISTIQ ER 114 91 78 394
CARVEDILOL 114 114 78 20
DICYCLOMINE HCL 113 101 81 194
LYRICA 112 88 82 120
ACTONEL 106 94 83 196
INSULIN SYRINGE 103 103 84 76
NIFEDIPINE ER 101 98 85 67
VESICARE 100 98 86 209
METHYLPREDNISOLONE 97 94 87 78
ACTOPLUS MET 94 79 88 453
LANSOPRAZOLE 93 89 89 116
BYETTA 90 86 90 445
VENTOLIN HFA 89 80 91 88
LOSARTAN POTASSIUM 84 69 92 11
LEXAPRO 83 81 93 177
ALLOPURINOL 82 80 94 37
SUCRALFATE 82 76 94 219
PANTOPRAZOLE SODIUM 80 80 96 38
NYSTATIN 80 67 96 195
NIASPAN 80 59 96 175
RISPERIDONE 79 72 99 83
LANTUS 79 78 99 59
GLIPIZIDE 78 78 101 41
PREMARIN 78 78 R 101 217
ZOVIRAX 77 59 103 406
EXELON 76 76 104 129
CEPHALEXIN 74 67 105 142
ISOSORBIDE MONONITRATE ER 71 71 106 56
FORTEO 70 70 107 390
FLOVENT HFA 69 69 108 345
CLOBETASOL PROPIONATE 69 59 108 188
LIPITOR 67 58 110 113
FENOFIBRATE 65 56 111 50
NOVOLOG MIX 70-30 65 65 111 261
NASONEX 65 65 111 220
CREON 64 63 114 460
IBANDRONATE SODIUM 60 60 115 276
SYNTHROID 60 56 115 42
CLOTRIMAZOLE 60 60 115 375
PREDNISOLONE 59 55 118 545
BUMETANIDE 53 53 119 134
ABILIFY 51 47 120 205
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 49 120 36
ENABLEX 50 48 122 388
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.